Schedule 13G ownership disclosure
IBERE PHARMACEUTICALS
Security class unavailable · CUSIP: G46843127
Event date: 2022-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-23-000137
- Form type
- SC 13G
- Filer
- Hartree Partners, LP
- CIK
- CIK 1597857
- Filed
- Feb 08, 2023
- Reporting period
- Dec 31, 2022
- Description
- Schedule 13G beneficial ownership